LEA vs SRPT · P/E 14, rev $23.31B vs rev $1.90B
Lear Corporation (LEA) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Lear Corporation (LEA) is a auto parts company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported LEA revenue for 2024-12-31 was $23.31B. Net income was $591.8M. Revenue was down 0.7% from 2023-12-31 to 2024-12-31. LEA currently screens at market cap $7.21B and trailing P/E 14.4.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
LEA currently screens at market cap $7.21B and trailing P/E 14.4. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the LEA and SRPT stock pages for the full models.
Not investment advice.